Skip to main content
Recruiting Clinical Trials

MPM PDT Phase II Trial

By April 24, 2017No Comments

Condition

Epitheliod Malignant Pleural Mesothelioma

Estimated Enrollment: 102

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Primary Purpose: Treatment

Study ID Numbers: UPCC 14513

Study First Received: May 28, 2014

Last Updated: December 6, 2016

Estimated Primary Completion Date: May 2018

 

Primary Outcome Measures:

Number of adverse events

Sponsors and Collaborators:

Abramson Cancer Center of the University of Pennsylvania

Website Link: https://ClinicalTrials.gov/show/NCT02153229

Leave a Reply